Dual blockade of PD-1 and CTLA-4 with nivolumab and ipilimumab has been used to treat melanoma, renal cell carcinoma, and non-small-cell lung cancer in clinical trials [19,20,21]. This evidence concerns the gene CTLA4 and non-small cell lung carcinoma.